J075-2519 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide

J075-2519 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide
J075-2519 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J075-2519
N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J075-2519

Molecular Formula

C19H16FN3O2 (C19 H16 FN3 O2)

Compound Name

N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide

IUPAC name

N-{[5-(4-fluorophenyl)-124-oxadiazol-3-yl]methyl}-2-phenylcyclopropane-1-carboxamide

SMILES

O=C(C(C1)C1c1ccccc1)NCc1noc(-c(cc2)ccc2F)n1

InChI

InChI=1S/C19H16FN3O2/c20-14-8-6-13(7-9-14)19-22-17(23-25-19)11-21-18(24)16-10-15(16)12-4-2-1-3-5-12/h1-9,15-16H,10-11H2,(H,21,24)

InChI Key

VUFBUIKAUWXWJH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27223448

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

337.35

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.466

Distribution Coefficient, logD

3.466

Water Solubility, LogSw

-3.56

Polar Surface Area

57.571

Acid Dissociation Constant (pKa)

12.52

Base Dissociation Constant (pKb)

-4.26

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

21.10

J075-2519 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Cardiovascular Library (22201 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with J075-2519 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J075-2519?
Check Price and Availability of J075-2519, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J075-2519 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J075-2519
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J075-2519
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J075-2519 available by request